Loading [Contrib]/a11y/accessibility-menu.js
Review Topical Sections

Nucleosome dynamics: HMGB1 facilitates nucleosome restructuring and collaborates in estrogen-responsive gene expression

  • Received: 08 October 2016 Accepted: 23 November 2016 Published: 02 December 2016
  • The genome in the human cell is extraordinarily compacted in the nucleus. As a result, much of the DNA is inaccessible and functionally inert. Notwithstanding the highly efficient packaging, mechanisms have evolved to render DNA sites accessible that then enable a multitude of factors to carry out ongoing and vital functions. The compaction is derived from DNA complexation within nucleosomes, which can further consolidate into a higher-order chromatin structure. The nucleosome and nucleosomal DNA are not static in nature, but are dynamic, undergoing structural and functional changes as the cell responds to stresses and/or metabolic or environmental cues. We are only beginning to understand the forces and the complexes that engage the nucleosome to unearth the tightly bound and inaccessible DNA sequences and provide an opening to more accessible target sites. In many cases, current findings support a major role for the action of ATP-dependent chromatin remodeling complexes (CRCs) in providing an avenue to factor accessibility that leads to the activation of transcription. The estrogen receptor α (ERα) does not bind to the estrogen response element (ERE) in the canonical nucleosome. However, evidence will be presented that HMGB1 restructures the nucleosome in an ATP-independent manner and also facilitates access and strong binding of ERα to ERE. The features that appear important in the mechanism of action for HMGB1 will be highlighted, in addition to the characteristic features of the restructured nucleosome. These findings, together with previous evidence, suggest a collaborative role for HMGB1 in the step-wise transcription of estrogen-responsive genes. In addition, alternate mechanistic pathways will be discussed, with consideration that “HMGB1 restructuring” of the nucleosome may generally be viewed as a perturbation of the equilibrium of an ensemble of nearly isoenergetic nucleosome states in an energy landscape that is driven by conformational selection by HMGB1.

    Citation: William M. Scovell. Nucleosome dynamics: HMGB1 facilitates nucleosome restructuring and collaborates in estrogen-responsive gene expression[J]. AIMS Genetics, 2016, 3(4): 252-279. doi: 10.3934/genet.2016.4.252

    Related Papers:

    [1] Yoshie Uchida, Masaki Honda, Rungaroon Waditee-Sirisattha, Hakuto Kageyama . Functional evaluation of saclipins A and B derived from the edible cyanobacterium Aphanothece sacrum: New bioactivities for anti-wrinkle and anti-hypertension. AIMS Molecular Science, 2025, 12(2): 113-121. doi: 10.3934/molsci.2025007
    [2] Abdulrahman Mahmoud Dogara, Ateeq Ahmed Al-Zahrani, Sarwan W. Bradosty, Saber W. Hamad, Aisha Abdullahi Mahmud, Hussain D. Almalki, Mustapha Abdullahi, Abubakar Abdullahi Lema, Hasan Nudin Nur Fatihah . In-vitro biological activity and in-silico studies of some volatile phytochemicals from the ethanol extract of Eugenia uniflora. AIMS Molecular Science, 2024, 11(3): 303-321. doi: 10.3934/molsci.2024018
    [3] Yuri Pevzner, Daniel N. Santiago, Jacqueline L. von Salm, Rainer S. Metcalf, Kenyon G. Daniel, Laurent Calcul, H. Lee Woodcock, Bill J. Baker, Wayne C. Guida, Wesley H. Brooks . Virtual target screening to rapidly identify potential protein targets of natural products in drug discovery. AIMS Molecular Science, 2014, 1(2): 81-98. doi: 10.3934/molsci.2014.2.81
    [4] Harkirat S. Sethi, Jessica L. Osier, Geordan L. Burks, Jennifer F. Lamar, Hana McFeeters, Robert L. McFeeters . Expedited isolation of natural product peptidyl-tRNA hydrolase inhibitors from a Pth1 affinity column. AIMS Molecular Science, 2017, 4(2): 175-184. doi: 10.3934/molsci.2017.2.175
    [5] Patrizia A d'Alessio, Marie C Béné, Chantal Menut . d-Limonene challenging anti-inflammatory strategies. AIMS Molecular Science, 2022, 9(2): 46-65. doi: 10.3934/molsci.2022003
    [6] Ahmed A. Zaky, Muhammad Usman Akram, Katarzyna Rybak, Dorota Witrowa-Rajchert, Malgorzata Nowacka . Bioactive compounds from plants and by-products: Novel extraction methods, applications, and limitations. AIMS Molecular Science, 2024, 11(2): 150-188. doi: 10.3934/molsci.2024010
    [7] Nguyen Hoai Nguyen . HY5, an integrator of light and temperature signals in the regulation of anthocyanins biosynthesis in Arabidopsis. AIMS Molecular Science, 2020, 7(2): 70-81. doi: 10.3934/molsci.2020005
    [8] Fohona S. Coulibaly, Danielle N. Thomas, Bi-Botti C. Youan . Anti-HIV lectins and current delivery strategies. AIMS Molecular Science, 2018, 5(1): 96-116. doi: 10.3934/molsci.2018.1.96
    [9] Alessandro Venditti, Claudio Frezza, Diana Celona, Fabio Sciubba, Sebastiano Foddai, Maurizio Delfini, Mauro Serafini, Armandodoriano Bianco . Phytochemical comparison with quantitative analysis between two flower phenotypes of Mentha aquatica L.: pink-violet and white. AIMS Molecular Science, 2017, 4(3): 288-300. doi: 10.3934/molsci.2017.3.288
    [10] Luís J. del Valle, Lourdes Franco, Ramaz Katsarava, Jordi Puiggalí . Electrospun biodegradable polymers loaded with bactericide agents. AIMS Molecular Science, 2016, 3(1): 52-87. doi: 10.3934/molsci.2016.1.52
  • The genome in the human cell is extraordinarily compacted in the nucleus. As a result, much of the DNA is inaccessible and functionally inert. Notwithstanding the highly efficient packaging, mechanisms have evolved to render DNA sites accessible that then enable a multitude of factors to carry out ongoing and vital functions. The compaction is derived from DNA complexation within nucleosomes, which can further consolidate into a higher-order chromatin structure. The nucleosome and nucleosomal DNA are not static in nature, but are dynamic, undergoing structural and functional changes as the cell responds to stresses and/or metabolic or environmental cues. We are only beginning to understand the forces and the complexes that engage the nucleosome to unearth the tightly bound and inaccessible DNA sequences and provide an opening to more accessible target sites. In many cases, current findings support a major role for the action of ATP-dependent chromatin remodeling complexes (CRCs) in providing an avenue to factor accessibility that leads to the activation of transcription. The estrogen receptor α (ERα) does not bind to the estrogen response element (ERE) in the canonical nucleosome. However, evidence will be presented that HMGB1 restructures the nucleosome in an ATP-independent manner and also facilitates access and strong binding of ERα to ERE. The features that appear important in the mechanism of action for HMGB1 will be highlighted, in addition to the characteristic features of the restructured nucleosome. These findings, together with previous evidence, suggest a collaborative role for HMGB1 in the step-wise transcription of estrogen-responsive genes. In addition, alternate mechanistic pathways will be discussed, with consideration that “HMGB1 restructuring” of the nucleosome may generally be viewed as a perturbation of the equilibrium of an ensemble of nearly isoenergetic nucleosome states in an energy landscape that is driven by conformational selection by HMGB1.


    Coumarin nucleus is present in several plants. Studies have revealed that various phytoconstituents have been derived from coumarin nucleus that has pronounced anti-inflammatory activities. Certain coumarins-derived phytocompounds like columbiatnetin,visniadin, marmin, umbelliferon, scopoletin etc., have been reported to have potential anti-inflammatory activities. These compounds have also been reported to have potent antioxidant and radical scavenging potential which may complement their anti-inflammatory activities [1]. Coumarin derivatives which get synthesized naturally in various plants and also the compounds derived from coumarin and synthesized in laboratories, both are reported to have excellent anti-inflammatory effects. There have been several studies evaluating the anti-inflammatory and other pharmacological potential of natural and synthetic coumarin derivatives with the interest of developing useful and potent drugs for combating various pain and inflammatory conditions in animal bodies [2]. Studies show that the biological in vitro anti-inflammatory activities of coumarin derivatives are concentration-dependent [3].

    Inflammation is an essential, immuno-protective physiological response to any kind of irritant or aggression [4]. The reaction of inflammation may be localized or may be generalised depending on the intensity of the stimulus exposed to. Inflammation can get triggered by various factors. Some of these include injury, trauma, exposure to toxins, pathogen attack etc., [5]. Several immune cells act together when our body encounters any kind of inflammation. In the process, various different types of chemicals are released which include substances like histamine and bradykinin. Together those substances are called as inflammatory mediators. They all act together with a goal of removing the cause of inflammation and promoting a healing process. Thus, in a nutshell, inflammation is a protective mechanism of our body and is inevitable to maintain a good health [6]. Besides, other events that occur during inflammation are alteration in vascular permeability and leukocyte recruitment and accumulation [7]. These cause dilatation of the blood vessels which in turn facilitates movement and accumulation of more and more leukocytes at the site of inflammation. Leukocyte chemotaxis occurs from circulation to the site of inflammation [8]. Leukocytes fight back the infection and devour the pathogens to reduce the cause of inflammation and thus help to mitigate the condition of inflammation. Also, leukocytes release inflammatory mediators at the site of inflammation which causes further inflammatory responses [7]. Dilation of blood vessels causes swelling of the site of inflammation. The inflammatory mediators irritate the nerve endings at the site of inflammation and send a pain signal to our central nervous system making us aware of the occurrence of inflammation at a particular site in our body and thus we tend to take care of the inflamed site. The prime inflammatory mediators other than histamine and bradykinin are neuropeptides, cytokines, growth factors and neurotransmitters. Any kind of pain is reported to be having an origin of inflammation or inflammatory response [9].

    Studies conducted for several years reveal that coumarins and its derivatives can mitigate inflammation and inflammatory reactions by effecting different types of receptors like Toll-like receptors (TLR), and by effecting various signalling pathways and molecules which include the inflammasomes, Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), mitogen-activated protein kinase (MAPK), nuclear factor-κ-light-chain-enhancer of activated B cells (NF-κB) and transforming growth factor-β/small mothers against decapentaplegic (TGF-β/SMAD) pathways etc. [10]. Studies conducted using six different coumarins derivatives of plant source showed that they have potent anti-inflammatory effects against intestinal inflammation. The study further reveals that the anti-inflammatory activities of these six coumarin derivatives, namely scopoletin, scoparone, fraxetin, 4-methyl-umbelliferone, esculin and daphnetin had a correlation to their antioxidant properties [11]. Certain coumarins derived from natural plant products like esculetin, fraxetin, daphnetin etc., have been evaluated and are reported as inhibitors of lipoxygenase and cyclooxygenase (COX) enzymes [12]. COX plays an important role in the biosynthesis of prostaglandins H2 from arachidonic acid (AA). Prostaglandin H2 is a precursor for various molecules like prostaglandins, prostacyclins and thromboxanes which play crucial roles in the pathophysiology of pain and inflammation [13]. The natural coumarin derivatives have also been recognised to have inhibitory effects on neutrophil-dependent superoxide anion generation [12]. These findings show that the natural coumarin derivatives possess both anti-nflmmatory and antioxidant potential thus qualifying as them as excellent candidates for the development of anti-inflammatory drugs.

    Coumrain compounds have been reported to be present in various plants naturally. These compounds are known to be present in a pretty high concentration in tonka bean i.e., Coumarouna odorata (Fabaceae) [14]. Other plants reported to be rich in coumarin compounds are cassia cinnamon and liquorice [15]. Licorice is known as liquorice, kanzoh in Japanese and is known as gancao in Chinese. It is actually the name applied to the roots and stolons of some Glycyrrhiza species (Leguminosae or Fabaceae). The genus Glycyrrhiza consists of almost 30 species [16]. Licorice is known to be used by human since ages. Vanilla grass, Anthoxanthum odoratum is also reported to be rich in coumarins compounds [17]. Sweet clover Melilotus sp. is also reported to be rich in coumarin compounds [18]. Besides these, Justicia pectoralis, Ferula L., Pachypleurum Hoff., Prangos Lindl., Heracleum L., Conioselinum Fisch., Libanotis L., Seseli L etc. were found to be containing various types of coumarins compounds [19]. Cherry blossoms, apricots and strawberries also contain coumarin compounds but in smaller quantities [19]. Studies reveal that more than one thousand and three hundred coumarins have been identified from various plant sources [20].

    Coumarins are natural benzopyrone compounds (2H-1-benzopyran-2-one), widely and commonly distributed in many medicinal plants. These are actually fused benzene and α-pyrone rings. These compounds have been reported to have a wide variety of pharmacological potentials which include ani-inflammatory, anti-malarial, anti-viral, anti-fungal, neuro-protective, anti-convulsant, anti-hypertensive, antibacterial, anti-coagulant, anticancer etc. [14] Each of these bio-potential of coumarins have significant pharmacological value. Our aim in this review is to highlight the anti-inflammatory potential of the natural coumarins compounds from the plants of Indo-Gangetic plains.

    Table 1 represents the list of some potent anti-inflammatory compounds and the plants they have been recognized to be present in. The mechanism of anti-inflammatory of these coumarins compounds isolated from plants of Indo-Gangetic plains are also mentioned in the table in brief.

    Besides the plants mentioned in Table 1, cherry blossoms, apricots and strawberries also contain coumarin compounds in smaller quantities [19]. Studies reveal that more than one thousand and three hundred coumarins have been identified from various plant sources [20]. Studies reveal presence of coumarin compounds in plants like Hypericum perforatum (Saint John Wort), Uncaria tomentosa (Cat's Claw), Passiflora incarnata (Passion Flower), Aesculus hippocastanum (Horse-chestnut), Tilia cordata (Lime Tree), Lawsonia inermis (Henna) etc. [21].

    Table 1.  Coumarin compounds, their source plants and brief mechanism of anti-inflammatory activities.
    Sl No. Coumarin compounds IUPAC name Formula Structure Plant (common names) Scientific names Mode of anti-inflammatory action References
    1 Scopoletin 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one C10H8O4 Datura or Indian thornapple Datura metel Works by inhibiting the pro-inflammatory cytokines [22][25]
    Virgate wormwood Artemisia scoparia
    Resinous kamala Mallotus resinosus
    Fenugreek Trigonella foenum-graecum
    2 Scoparone 6,7-dimethoxychromen-2-one C11H10O4 Virgate wormwood Artemisia scoparia Works primarily by suppressing the NF-κB signalling inflammatory pathway [26][29]
    Wormwood Artemisia absinthium
    3 Fraxetin 7,8-Dihydroxy-6-methoxy-2H-1-benzopyran-2-one C10H8O5 Thale cress, mouse-ear cress or arabidopsis Arabidopsis thaliana Works by suppressing pro-inflammatory cytokines induced NF-κB signalling inflammatory pathway [30][33]
    Datura or trumpet flower Datura stramonium
    4 Fraxinol 6-hydroxy-5,7-dimethoxychromen-2-one C11H10O5 Prostrate cherry, mountain cherry, Rock Cherry, Creeping Cherry, Spreading Cherry Prunus prostrata Works by by inhibiting T-cells and prostaglandin biosynthesis [34][37]
    5 Umbelliferone 7-hydroxychromen-2-one C9H6O3 Coriander Toothbrush Tree, Miswak Coriandrum sativum Salvadora persica Works by suppressing and downregulating certain genes involved in inflammatory pathways like the genes of TLR4 and NF-κB [38][41]
    6 6-hydroxy-7-methoxy-4 methyl coumarin 6-hydroxy-7-methoxy-4-methylchromen-2-one C11H10O4 Bishop's flower, false bishop's weed, laceflower, bullwort, lady's lace, false Queen Anne's lace Ammi majus Reported to exhibit anti-inflammatory activity in vivo in carrageenan-induced rat paw edema protocol [42][45]
    7 4-methyl-umbelliferone 7-hydroxy-4-methylchromen-2-one C10H8O3 Bishop's flower, false bishop's weed, laceflower, bullwort, lady's lace, false Queen Anne's lace Ammi majus Works by inhibiting the pro-inflammatory cytokines [46],[47]
    8 Isofraxidin 7-hydroxy-6,8-dimethoxychromen-2-one C11H10O5 Celery Apium graveolens Works by reducing pro-inflmmatory cytokines and by attenuating the increased expression of inflammatory enzymes [48][51]
    9 Esculin 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one C15H16O9 Barley Hordeum spontaneum Reported to work by reducing proinflammatory and inflammatory cytokines [52][54]
    10 Scopolin or Murrayin or Scopoletin 7-glucoside 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one C16H18O9 Thale cress, mouse-ear cress or arabidopsis Arabidopsis thaliana Reported to work by reducing proinflammatory and inflammatory cytokines [55][63]
    Mugwort, wormwood, Artemisia minor
    Orange berry and gin berry Glycosmis pentaphylla
    Orange jasmine, orange jessamine, china box or mock orange Murraya paniculata
    11 Ostruthin 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one C19H22O3 Kurantu
    Kuruntu
    Perum Kuruntu
    Kadanaathi
    Pamburus missionis Known to work by suppressing iNOS and COX-2 protein expression. [64][67]
    Indian coffee plum, or scramberry Flacourtia jangomas
    12 3′,5,7-Trihydroxy-4-methoxyflavanone or 5-O-methylscutellarein 5,7-dihydroxy-2-(3-hydroxyphenyl)-4-methoxy-4H-chromen-3-one C16H14O6 Turmeric Curcuma zedoaria Works by suppressing NF-κB activation, reduces cholesterol biosynthesis and Inhibits lipid peroxidation [68][74]
    13 7-methoxy coumarin (herniarin, 3) or Herniarin. 7-methoxychromen-2-one C10H8O3 Turmeric Curcuma zedoaria Reported to work by inhbiting writhing and nociception [75][78]
    White mugwort Artemisia lactiflora
    Ruptureworts Herniaria
    Ayapan Eupatorium Triplinerve
    14 Auraptene 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]chromen-2-one C19H22O3 Kaminmi, orange jasmine, orange jessamine, china box or mock orange Murraya paniculata Works by reducing oxidative stress, suppresses various proinflammatory cytokines, inflammatory mediators and the enzymes involved in inflammation [61],[79][82]
    15 Silibinin (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one C25H22O10 Milk thistle, blessed milkthistle, Marian thistle, Mary thistle, Saint Mary's thistle, Mediterranean milk thistle, variegated thistle and Scotch thistle Silybum marianum Reported to work by reducing proinflammatory and inflammatory cytokines [83][89]
    16 Murracarpin 8-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxychromen-2-one C16H18O5 Kaminmi, orange jasmine, orange jessamine, china box or mock orange Murraya paniculata, Works by inhibiting the elevation of IL-1β, TNF-α, and PGE2 [90][95]
    Curry patta, meetha neem Murraya koenigii
    White Himalayan Rue Boenninghausenia albiflora
    Orangeberry and gin berry Glycosmis pentaphylla
    17 Murrangatin 8-[(1R,2S)-1,2-dihydroxy-3-methylbut-3-enyl]-7-methoxychromen-2-one C15H16O5 Curry patta, meetha neem Murraya koenigii Works by downregulation of IL-1β, TNFα, PGE2, and MMP-13 etc. [96][100]
    Murraya paniculata,
    18 Daphnetin 7,8-dihydroxychromen-2-one C9H6O4 Indian Paper Plant, Indian paper tree, Nepali paper plant Daphne papyracea Suppresses activation of macrophages and proinflammatory cytokines and down-regulates NF-κB-dependent signalling events. Induces expression of anti-inflammatory cytokines [101][106]
    Himalayan Stellera Stellera chamaejasme
    sweet wormwood, sweet annie, sweet sagewort, annual mugwort Artemisia annua
    19 Marmin 7-[(E,6R)-6,7-dihydroxy-3,7-dimethyloct-2-enoxy]chromen-2-one C19H24O5 bael (or bili) or bhel, also Bengal quince, golden apple, Japanese bitter orange, stone apple or wood apple Aegle marmelos Works by lowering nuclear factor kappa-B (NF-κB) [107][112]
    Citron, rough lemon Citrus medica
    20 Psoralen furo[3,2-g]chromen-7-one C11H6O3 wood-apple and elephant-apple Limonia acidissima Works via estrogen receptor signalling pathway [113][117]

     | Show Table
    DownLoad: CSV

    Coumarins exhibit their anti-inflammatory activities through various molecular mechanisms. Different coumarins compounds follow different molecular mechanisms to ultimately mitigate inflammation.

    As evident from study conducted on mice, scopoletin is known to have inhibitory activity on PGE2 and TNF-α overproduction, and neutrophil infiltration. Also, it is reported that scopoletin significantly attenuates the malondialdehyde (MDA) level in the edema paw of experimental mice. Thus, scopoletin inhibits the pro-inflammatory cytokines and exhibits its anti-inflammatory activity [25]. Another coumarin named Scoparone, is reported to prevent IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway. Scoparone is also known to suppressing the TLR4/NF-κB signalling pathway in mice which in turn mitigates inflammation, apoptosis and fibrosis associated with non-alcoholic steatohepatitis [28],[29]. The other coumarin, fraxetin is reported to exhibit its anti-inflammatory activity by the mechanism of suppressing IL-1β-induced inflammation via the TLR4/MyD88/NF-κB pathway in rat chondrocytes. Also,the other molecular mechanism of the anti-inflammatory activity of fraxetin is by imparting a suppression effect on microglia-mediated neuroinflammation, and this effect is associated with the PI3K/Akt/NF-κB signalling pathway [32],[33]. Fraxinol, another known coumarin compound with anti-inflammatory activity is known to reduce inflammation by the mechanism of inhibiting the T-cells and prostaglandin biosynthesis [37].

    Umbelliferon, a very common coumarins compound with widely reported anti-inflammatory activity works by significantly suppressing the hepatic lipopolysaccharide binding protein, toll-like receptor 4 (TLR4), nuclear factor kappa B, and TNF-α gene expression in alcohol fed rats and thus prevents alcohol-induced inflammation in rat hepatic tissue [39]. Also, Umbelliferon is known to reduce lipopolysaccharide-induced inflammatory responses in acute lung injury by down-regulating TLR4/MyD88/NF-κB signalling [40]. Isofraxidin, another coumrin is reported to impart its anti-inflammatory activity by decreasing the lipopolysaccharide (LPS)-induced overproduction of nitric oxide (NO), prostaglandin E2 (PGE2), tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Isofraxidin is also nreported to mitigate the increased expression of inflammatory enzymes, like inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), in response to LPS stimulation and thus helps to reduce LPS-induced inflammation [50],[51].

    Esculin, the coumarins is also a well reported anti-inflammatory coumarins. The basic molecular mechanism of action of this coumarin is reported to be by decreasing the cytokines IL-1, IL-6, ICAM-1, NO and NGAL levels in serum of diabetic rats in a dose dependent manner thus reducing the risks of microvascular complications associated with diabetes [54]. Scopolin, another aanti-inflammatory coumarins compound is known to exhibit its anti-inflammatory action by the molecular mechanism of inhibiting eicosanoid-release from ionophore-stimulated mouse peritoneal macrophages. Also, scopolin is known to reduce IL-6, VEGF and FGF-2 expressions in rat synovial tissue [62],[63]. The molecular mechanism of the anti-inflammatory activity of the coumarins, Ostruthin is reported to be by suppressing LPS-induced iNOS and COX-2 protein expressions [67]. 5-O-methylscutellarein, is known to impart its anti-inflammatory potential by suppressing the NF-κB [70]. Auraptene is also known to have anti-inflammatory activity. Studies show that treatment with auraptene (10-90 µM) significantly ameliorates ROS, MDA, IL-6, and TNF-α levels. Also, studies show that Auraptene, as a pre-treatment for five days before and another three days after ischemic surgery, suppressed microglial activation, cyclooxygenase (COX)-2 expression in astrocytes, and COX-2 mRNA expression in the hippocampus. Other underlying molecular mechanism of the anti-inflammatory activity of the coumarin auraptene is by suppressing the lipopolysaccharide-induced expression of COX-2 mRNA and the mRNA of pro-inflammatory cytokines in cultured astrocytes. It is also reported to have the capacity to interfere with inflammatory mediator secretion and to promote wound healing [81],[82].

    Silibinin is known to have potent anti-inflammatory activity and the underlying molecular mechanism is reported to be by altering the level of various pro-inflammatory cytokines. Studies conducted in vitro using human fetal membranes reports that the coumarins, silibinin has the ability to significantly decrease LPS-stimulated expression of IL-6 and IL-8, COX-2, and prostaglandins PGE2 and PGF2α. In primary amnion and myometrial cells, silibinin is also reported to decrease the IL-1β-induced MMP-9 expression.Preterm fetal membranes with active infection treated with silibinin shows a decrease in IL-6, IL-8 and MMP-9 expression. Fetal brains from mice treated with silibinin shows a significant decrease in LPS-induced IL-8 and ninjurin, a marker of brain injury. Other studies show that Silibinin is capable of reducing, at least in part, the levels of NF-κB and cytokines TNF-α and IL-1β in preeclamptic women. Also, Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats [88],[89]. Murracarpin is another potent anti-inflammatory coumarin. In carrageenin pleurisy model, murracarpin is reported to effectively inhibit the elevation of IL-1β, TNF-α, and PGE2 and thus mitigate inflammation therein [95].

    Another coumarins compound with reported anti-inflammatory potential is murrangatin. One of the reported molecular mechanism of the anti-inflammatory activity of murrangatin is by downregulation of IL-1β, TNFα, PGE2, and MMP-13. By this mechanism it the compound imparts chondroprotective activity, Other studies show that Murrangatin has anti-inflammatory activity against mouse RAW264.7 cells the underlying mechanism of which is by reduction of LPS-induced NO production after 24 hrs by the compound [99],[100]. Daphnetin, is also another reported anti-inflammatory coumarins. Studies show that one of the mechanisms of anti-inflammatory activity of the compound is by suppression of the activation of macrophage and human alveolar epithelial cells in response to lipopolysaccharide (LPS). This in turn is related to the down-regulation of NF-κB-dependent signalling events. Also, Daphnetin treatment is reported to significantly decrease the expression of pro-inflammatory cytokines and cause increased expression of anti-inflammatory cytokines in rat SAP. Molecular analysis reveals that daphnetin reduces TLR4 expression and inhibits NF-κB signalling pathway activation. These findings demonstrate that daphnetin attenuates acute pancreatic injury by regulating the TLR4/ NF-κB signalling pathway and inflammation in rat SAP model [102],[106]. Marmin is another reported coumarins compound with anti-inflammatory potential. Extracts of plants containing marmin have been reported to exhibit potent anti-inflammatory activities. Studies reveal that marmin works by lowering the nuclear factor kappa-B (NF-κB) and thus reduces inflammation[113]. The coumarin, psoralen is known to exhibit anti-inflammatory effects on synoviocytes, and mitigate monosodium iodoacetate-induced osteoarthritis. The mechanism of anti-inflammatory activity of psoralen in human periodontal ligament cells is reported to be via estrogenic receptor signalling pathway [114].

    There are many more such coumarins compounds abundantly distributed in nature. The molecular mechanism of the anti-inflammatory activity of each of these coumarins are unique and varies from each other. The basic molecular mechanism of the anti-inflammatory activity of the coumarins seems to be by altering and effecting the anti-inflammatoy and pro-inflammatory cytokines associated with inflammation in various tissues.

    Coumarins are widely distributed in nature in various plants. Theses potent phyto-constituents are extracted and purified by conventional methods of phytocompounds extraction. Various extraction techniques that are in use for isolating and purifying coumarins from plants are maceration, ultrasound maceration [118]. By these techniques, basically the plant material is macerated and the plant cells are broken down releasing the cellular content which includes the coumarins compounds along with many other compounds. In certain cases, the plant material in whole or after maceration or homogenization is infused with aqueous ethanol, water, methanol, ethyl acetate, chloroform, diethyl ether, or other solvents etc. [119],[120]. The coumarins compounds thus gets in dissolution into the suitable solvent and is then subjected to further purification process. The prime technique used commonly for purification and isolation of such phytocompounds as the coumarins is chromatography. Mostly various types of column chromatography is utilized coupled with or in some cases followed by high throughput liquid chromatography which is often coupled with fine analytical instruments like photodiode array detector (DAD) etc. After the purified fraction is compared against standards and collected from those analytical techniques, those are further subjected to finer analysis for understanding and interpretation of the composition and prediction of the molecular structure of the compounds. Techniques like MALDI TOFF, Scanning Electron microscopy, X-Ray Crystallography etc. are used for structural analysis of the purified coumarins. Some of the techniques used for purification and isolation of the coumarins involve utilization of various sophisticated analytical instruments like high performance liquid chromatography with UV detector (HPLC-UV) [121], reverse-phase high-performance liquid chromatographic method (RP-HPLC) coupled with a photodiode array detector (DAD) [122] etc., Also, other instruments like Scanning Electron Microscope (SEM)[123], Soxhelation, Ultrasonic-assisted response surface methodology (RSM) [123] etc. are used for extended procedures of extract1ion of coumarins from various plant sources.

    Natural Coumarin compounds come from plant sources and are thus devoid of much or any side effects unlike synthetic pharmaceutical compounds and formulations. These natural compounds can be used in combination with other pharmaceutical combinations. Studies reveal that most of the coumarins compounds exhibit anti-inflammatory as well as antioxidant activities. Hence, this makes these natural bioactive coumarins a perfect and potent candidate for developing potential anti-inflammatory drug formulations with dual benefits [124]. On one hand these act as effective anti-inflammatory agents impacting and regulating various pathways associated with pain and inflammation and on the other hand coumarins by virtue of their antioxidant potential reduces the oxidative stress mediated complications of inflammation and also is easy to be processed and metabolized by our liver. Overall, the properties of natural bioactive coumarins make them safer anti-inflammatory agents compared to other anti-inflammatory agents [124]. Studies show that non-steroidal anti-inflammatory drugs (NSAIDs) like piroxicam may be harsh on the gastric mucosal lining and may induce gastric ulcers. Whereas, these natural coumarin compounds from the plants of Indo-gangetic possess antioxidant potentials and they have been reported to be protective on gastric mucosa and are known not to induce oxidative stress there in unlike NSAIDs [124]. In addition to these magical miraculous properties of the natural coumarins compounds, they have been found to be adequately bio-available [124] which further qualifies them as suitable candidates for developing anti-inflammatory formulations. Coumarins are known to scavenge reactive oxygen species and thus are capable of effecting and influencing processes involving free radicals-induced injury and damages [125]. With all these benefits, coumarin compounds being available from natural resources can be easily isolated and can be used for developing better derivatives if needed and thus can be immensely utilised for developing potent anti-inflammatory pharmaceutical formulations with minimum side effects. Also, the lead coumarins compounds being mostly extracted from natural sources, it is expected that the anti-inflammatory drugs developed using natural coumarins and their derivatives will be potent, safer, better, cost effective and affordable.

    The micro and macronutrient composition of the soil varies as per the geographical regions. Thus, the plants growing in the indo-gangetic region and those growing in other regions vary in their composition. The potency of these bioactive phytocompounds are also reported to vary depending on the variation of the geographical region and soil composition. In vitro studies conducted on Murraya koenigi collected from different districts of the state of West Bengal, India is reported to have varied in their antioxidant potential [126]. Depending on the region , the climate and the soil composition, certain plants grow only in specific regions. Coumarins from those plants growing in other regions than the indo-gangetic plain have also been reported to exhibit potent anti-inflammatory activities. Thus, some of the coumarins compounds which are found in specific plants which do not grow in the indo-gangetic region are available in the plants which grow in other regions. High concentrations of coumarins are reported to be present in plants like Justicia pectoralis [127] which grows in the tropical areas of the Americas, including South and Central America and also grows in some Caribbean islands like Trinidad and Tobago [128], Dipteryx odorata (old name Coumarouna odorata) (tonka bean) (Fabaceae/Leguminosae) [129] which is also a tropical South American plant [130], Studies report high content of coumarins in plants like vanilla grass (Anthoxanthum odoratum) [131] which is native to acidic grassland in Eurasia and northern Africa [131] and many others. Studies also report abundant distribution of coumarins compounds in various plants from several plants grown exclusively in China and other parts of Eurasia. Those coumarins have potent bioactivities including anti-inflammatory activities. Phytoconstituents of plants like Cinnamomum cassia etc. has been evaluated to have potent anti-inflammatory activities in various experimental models and those plants have also been reported to be rich in coumarins [130]. Mostly, the type of coumarin compounds found in the plants from Indo-Gangetic region differ in their chemical structure from those obtained from the plants grown in other regions. Also, the biopotential of the same coumarins compounds obtained from same or different plant may vary depending on the composition of the soil the plant has grown in.

    Investigations on the anti-inflammatory property of the natural coumarins compounds from various plants of the indo-gangetic plain delineated the basic mechanism to involve lowering of various pro-inflammatory cytokine levels including NF-κB and by altering the levels of prostaglandins [68],[78]. Some others alter the quantity of cytokines which are involved in the mechanism of inducing pain and inflammation [69][75]. Studies reveal that potent antioxidant activities complement the anti-inflammatory potential of the natural coumarins and their derivatives [124],[125]. Extensive research findings around the world involving investigations on the identification, isolation and anti-inflammatory potentials of the coumarin compounds from various regional endogenous plants and their derivatives, confirms the possibility of discerning coumarins as highly potent, cost effective and safe future anti-inflammatory therapeutic agents.

    [1] Krebs JE, Lewin B, Goldstein ES, et al. (2014) Lewin‘s Genes XI, Jones & Bartlett Learning Publishers, Burlington, MA.
    [2] Becker PB, Horz W (2002) ATP-dependent nucleosome remodeling. Annu Rev Biochem 71: 247-273.
    [3] Becker PB, Workman JL (2013) Nucleosome remodeling and Epigenetics, in Cold Spring Harbor Perspectives in Biology, Editors: Allis, CD, Caparros, ML, Jenuwein, T & Reinberg, D. Cold Spring Harbor Laboratory Press, 1-19.
    [4] Formosa T (2012) The role of FACT in making and breaking nucleosomes. Biochim Biophys Acta 1819: 247-255.
    [5] McGinty RK, Tan S (2014) Nucleosome structure and function. Chem Rev 115: 2255-2273.
    [6] Lugar K, Dechassa ML, Tremethick DJ (2012) New insights into nucleosome and chromatin structure: An ordered state or a disordered affair? Nat Rev Mol Cell Biol 13: 436-447.
    [7] Lugar K, Mader AW, Richmond RK, et al. (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
    [8] White CL, Lugar K (2004) Defined structural changes occur in a nucleosome upon Amt1 transcription factor binding. J Mol Biol 342: 1391-1402.
    [9] Richmond TJ, Davey CA (2003) The structure of DNA in the nucleosome core. Nature 423: 145-150.
    [10] Churchill ME, Travers AA (1991) Protein motifs that recognize structural features of DNA. Trends Biochem Sci 16: 92-97.
    [11] Bewley CA, Gronenborn AM, Clore GM (1998) Minor groove binding architectural proteins: Structure, function and DNA recognition. Annu Rev Biophys Biomol Struct 27: 105-131.
    [12] Rhodes D (1997) The nucleosome core all wrapped up. Nature 289: 232-233.
    [13] Chakravarthy S, Park YJ, Chodaparambil J, et al. (2005) Structure and dynamic properties of nucleosome core particles. FEBS Letts 579: 895-898.
    [14] Cairns BR (2007) Chromatin remodeling: Insights and intrigue from single-molecule studies. Nature Struct Mol Biol 14: 989-996.
    [15] Davey CA, Sargent DF, Lugar K, et al. (2002) Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 A resolution. J Mol Biol 319: 1097-1113.
    [16] Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21: 381-395.
    [17] Zhang C, Hayes JJ (2003) Structure and interactions of the core histone tail domains. Biopolymers 68: 539-546.
    [18] Strahl BD, Allis CD (2001) The language of histone modifications. Nature 403: 41-45.
    [19] Gordon F, Lugar K, Hansen JC (2005) The core histone N-terminal tail domains function independently and additively during salt-dependent oligomerization of nucleosome arrays. J Biol Chem 280: 33701-33706;
    [20] Shogrin-Knaak M, Ishii H, Sun J, et al. (2006) Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844-847;
    [21] Dorigo B, Schalch T, Bystricky K, et al. (2003) Chromatin fiber folding: Requirement for the histone H4 N-terminal tail. J Mol Biol 327: 85-96.
    [22] Lee DY, Hayes JJ, Pruss D, et al. (1993) A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72: 73-84.
    [23] Fry CJ, Peterson CL (2001) Chromatin remodeling enzymes: who’s on first? Curr Biol 11: R185-197.
    [24] Peterson CL, Workman JL (2000) Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr Opin Genet Dev 10: 187-192.
    [25] Bernstein BE, Lui CL, Humphrey EL, et al. (2004) Global nucleosome occupancy in yeast. Genome Biol 5: R62.
    [26] Suto RK, Clarkson MJ, Tremethick DJ, et al. (2000) Crystal structure of a nucleosome core particle containing the variant histone H2A.Z. Nature Struct Biol 7: 1121-1124:
    [27] Jin C, Felsenfeld G (2007) Nucleosome stability mediated by histone variants H3.3 and H2A.Z Genes Dev 21: 1519-1529); Reid, G Gallais, R, Metivier, R (2009) Marking time: The dynamic role of chromatin and covalent modification in transcription. Intl J Biochem Cell Biol 41: 135-153.
    [28] Gautier T, Abbott DW, Malla A, et al.. (2004) Histone variant H2ABbd confers lower stability to the nucleosome. EMBO Reports 5: 715-720.
    [29] Andrews A, Lugar K (2011) Nucleosome structure(s) and stability: Variations on a theme. Annu Rev Biophys 40: 99-117.
    [30] Chen J, Kinyamu K, Archer TK (2006) Changes in attitude, changes in latitude: Nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol 20: 1-13.
    [31] Borggrefe T, Yue X (2011) Interactions between subunits of the Mediator complex with gene-specific transcription factors. Semin Cell Dev Biol 22: 759-768.
    [32] Plaschka C, Nozawa K, Cramer P (2016) Mediator architecture and RNA polymerase II interactions. J Mol Biol 428: 2569-2574.
    [33] Malik S (2016) Eukaryotic transcription regulation: Getting to the heart of the matter: Commentary on Mediator architecture and RNA polymerase II by Plaschka et al. J Mol Biol 428: 2575-2580.
    [34] Zaret KS, Carroll JS (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25: 2227-2241.
    [35] Li Q, Wrange O (1995) Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol 15: 4375-4384.
    [36] Beato M, Eisfeld K (1997) Transcription factor access to chromatin, Nucleic Acids Res 25: 3559-3563.
    [37] Taylor ICA, Workman JL, Schuetz TJ, et al. (1991) Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: differential function of DNA binding domains. Genes Dev 5: 1285-1298.
    [38] Pifia B, Bruggemeier U, Beato M (1990) Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 60: 719-731.
    [39] Eisfeld K, Candau R, Truss M, et al. (1997) Binding of NF1 to the MMTV promoter in nucleosomes: Influence of rotational phasing, translational positioning and histone H1. Nucleic Acids Res 25: 3733-3742.
    [40] Imbalzano AN, Kwon H, Green MR, et al. (1994) Facilitated binding of the TATA-binding protein to nucleosomal DNA. Nature 270: 481-485.
    [41] Wechsler DS, Papoulas O, Dang CV, et al. (1994) Differential binding of c-Myc and Max to nucleosomal DNA. Mol Cell Biol 14: 4097-4107.
    [42] Angelov D, Charra M, Seve M, et al. (2000) Differential remodeling of the HIV-1 nucleosome upon transcription activators and SWI/SNF complex binding. J Mol Biol 302: 315-326.
    [43] Li B, Adams CC, Workman JL (1994) Nucleosome binding by the constitutive transcription factor Sp1. J Biol Chem 269: 7756-7763.
    [44] Galati A, Ressetti L, Pisano S, et al. (2006) The human telomeric protein TRF1 specifically recognizes nucleosomal binding sites and alters nucleosome structure. J Mol Biol 360: 377-385.
    [45] Pham TA, McDonnell DP, Tsai MJ, et al. (1992) Modulation of progesterone receptor binding to progesterone response elements by positioned nucleosomes. Biochemistry 31: 1570-1578.
    [46] Ng KW, Ridgway P, Cohen DR, et al. (1997) The binding of a Fos/Jun heterodimer can completely disrupt the structure of the nucleosome. EMBO J 16: 2072-2085.
    [47] Lone IN, Shulka MS, Richard JLC, et al. (2013) Binding of NF-κB to nucleosomes: Effect of translational positioning, nucleosome remodeling and linker H1. PLos 9: 9. e1003830.
    [48] White CL, Lugar K (2004) Defined structural changes occur in a nucleosome upon Amt1 transcription factor binding. J Mol Biol 342: 1391-1402.
    [49] Li Q, Wrange O (1993) Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes Dev 7: 2471-2482.
    [50] Gottesfeld, JM, Melander C, Suto RK, et al. (2001) Sequence-specific recognition of DNA in the nucleosome by pyrrole imidazole polyamides. J Mol Biol 309: 625-639.
    [51] Suto RK, Edayathumangalam RS, White CL, et al. (2003) Crystal structure of nucleosome core particle in complex with minor groove DNA–binding ligands. J Mol Biol 326: 371-380.
    [52] Cai Y, Jin J, Yao T, et al. (2007) YY1 functions with INO80 to activate transcription. Nature Struct Mol Biol 14: 872-874.
    [53] Fry CJ, Peterson CL (2001) Chromatin remodeling enzymes: who’s on first? Curr Biol 11: R185-197.
    [54] Wang W, Chi T, Xue Y, et al. (1998) Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complex. Proc Natl Acad Sci USA 95: 492-498.
    [55] Guertin MJ, Lis JT (2013) Mechanisms by which transcription factors gain access to target sequence elements in chromatin. Curr Opin Genet Dev 23: 116-123.
    [56] Carroll JS, Liu XS, Brodsky AS, et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein A1. Cell 122: 33-43.
    [57] Carroll JS, Meyer CA, Song J, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nature Genetics 38: 1289-1297.
    [58] Dahlman-Wright K, Qiao Y, Jonsson P, et al. (2012) Interplay between AP-1 and estrogen receptor in regulating gene expression and proliferation networks in breast cancer cells. Carcinogen 33: 1684-1691.
    [59] Uht RM, Anderson CM, Webb P, et al. (1997) Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 138: 2900-2908.
    [60] Krishman, V, Wang, X, Safe, S (1994) Estrogen receptor-Sp1 complexes mediate estrogen-induced Cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269: 15921-15917.
    [61] Swinstead EE, Miranda TB, Paakinaho V, et al. (2016) Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions. Cell 165: 593-605.
    [62] Joseph R, Oriov YL, Huss M, et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol 6: 1-13.
    [63] Ju BG, Lunyak VV, Perissi V, et al. (2004) A Topoisomerase IIβ–mediated dsDNA break required for regulated transcription. Science 312: 1798-1802.
    [64] Ruff M, Gangloff M, Wurtz JM, et al. (2000) Estrogen receptor transcription and transactivation structure-function relationship in DNA- and ligand-binding domains of estrogen receptors. Breast Cancer Res 2: 253-259.
    [65] Helding N, Pike A, Anderson S, et al. (2007) estrogen receptors: How do they signal and what are their targets. Physiolog Rev 87: 905-931.
    [66] Melvin VS, Harrell C, Adelman JS, et al. (2004) The role of the C-terminal extension (CTE) of the estrogen receptor and DNA binding domain in DNA binding and interaction with HMGB. J Biol Chem 279: 14763-14771.
    [67] Metivier R, Penot G, Carmouche RP, et al. (2004) Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes EMBO J 23: 3653-3666.
    [68] Berry M, Nunez AM, Chambon P (1989) Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86: 1218-1222.
    [69] Sewack GF, Hansen U (1997) Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter, J Biol Chem 272: 31118-31129.
    [70] Reid G, Gallais R, Metivier R (2009) Marking time: The dynamic role of chromatin and covalent modification in transcription. Intn J Biochem Cell Biol 41: 155-163.
    [71] Shang Y, Hu X, DiRenzo J, et al. (2000) Cofactors dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
    [72] DiRenzo J, Shang Y, Phelan M, et al. (2000) BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20: 7541-7549.
    [73] Sun L, Yang C, Zaidi M, et al. (2008) TNF-induced gene expression oscillates in time. Biochem Biophys Res Commun 371: 900-905.
    [74] Metivier R, Penot G, Hubner MR, et al. (2003) Estrogen receptor-α directs ordered, cyclical and combinational recruitment of cofactors on a natural target promoter. Cell 11: 751-763.
    [75] Metivier R, Reid G, Gannon F (2006) Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Reports 7: 161-167.
    [76] Malovannaya A, Lanz RB, Jung SY, et al. (2011) Analysis of the human endogenous coregulator complexome. Cell 145: 787-799.
    [77] Foulds CE, Feng Q, Ding C, et al. (2013) Proteomic analysis of coregulators bound to ER on DNA and nucleosomes reveal coregulator dynamics. Mol Cell 51: 185-199.
    [78] Parkkinen J, Raulo E, Merenmies J, et al. (1993) Amphoterin, the 30-kDa protein in a family of HMGB1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 268: 19726-19738.
    [79] Poser I, Golob M, Buettner R, et al. (2003) Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignant phenotype. Mol Cell Biol 23: 2991-2998.
    [80] Moisy D, Avilov SV, Jacob Y, et al. (2012) HMGB1 protein binds influenza virus nucleoprotein and promotes viral replication. J Virol 86: 122-133.
    [81] Nowak P, Barqasho B, Treutiger CJ, et al. (2006) HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages. Cytokine 34: 17-23.
    [82] Lange SS, Vasquez KM (2009) HMGB1: The jack-of-all-trades protein is a master DNA repair mechanic. Mol Carcinog 48: 571-580.
    [83] Kwon J, Imbalzano AN, Matthews A, et al. (1998) Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1. Mol Cell 2: 829-839.
    [84] Ellerman JE, Brown CK, deVera M, et al. (2007) Masquerader: High mobility group box-1 and cancer. Clin Cancer Res 13: 2836-2848.
    [85] Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by neurotic cells trigger inflammation. Nature 418: 191-195.
    [86] Qin S, Wang H, Yuan R, et al. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 203: 1637-1642.
    [87] Thomas JO, Travers AA (2001) HMG1 and HMG2 and related “architectural” DNA-binding proteins. Trends Biochem Sci 26: 167-174.
    [88] Waga S, Shirakawa H, Mizuno S, et al. (1990) The selective binding of HMGB1 to the cruciform DNA structure and the subsequent resumption of transcription. Nucleic Acids Symp Ser 22: 81-82.
    [89] Stott K, Watson M, Howe FS, et al. (2010) Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains. J Mol Biol 403: 706-722.
    [90] Wolffe AP (1994) Architectural transcription factors. Science 264: 1100-1101.
    [91] Bonaldi T, Langst G, Strohner R, et al. (2002) The DNA chaperone HMGB1 facilitates ACXF/CHRAC-dependent nucleosome sliding EMBO J 21: 6865-6873.
    [92] Ross ED, Hardwidge PR, Maher LJ (2001) HMG proteins and DNA flexibility in transcriptional activation Mol Cell Biol 21: 6598-6605.
    [93] Das D, Scovell WM (2001) The binding interaction of HMG-1 with the TATA-binding protein/TATA complex. J Biol Chem 276: 32597-32605.
    [94] Jayaraman L, Moorthy NC, Murthy KG, et al. (1998) High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12: 462-472.
    [95] Zappavigna V, Falciola L, Helmer-Citterich M, et al. (1996) HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. EMBO J 15: 4981-4991.
    [96] Butteroni C, De Felici M, Schöler HR, et al. (2000) Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins. J Mol Biol 304: 529-540.
    [97] Najima Y, Yahagi N, Takeuchi Y, et al. (2005) High mobility group protein-B1 interacts with sterol regulatory element-binding proteins to enhance their DNA binding. J Biol Chem 280: 27523-27532.
    [98] Agresti A, Lupo R, Bianchi ME, et al. (2003) HMGB1 interacts differentially with members of the Rel family of transcription factors. Biochem Biophys Res Commun 302: 421-426.
    [99] Yu M, Wang J, Li, et al. (2008) Proteomic screen defines the hepatocyte nuclear factor 1 alpha-binding partners and identifies HMGB1 as a new cofactor of HNF1alpha. Nucleic Acids Res 36: 1209-1219.
    [100] Mitsouras K, Wong B, Arayata C, et al. (2002) Two distinct modes of action that promote enhanceosome assembly. Mol Cell Biol 22: 4390-4401.
    [101] Oñate SA, Prendergast P, Wagner JP, et al. (1994) The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 14: 3376-3391.
    [102] Melvin VS, Edwards DP (1999) Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility proteins HMG-1 and -2. Steroids 64: 576-586
    [103] Das D, Peterson RC, Scovell WM (2004) High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol Endocrinol 18: 2616-2632.
    [104] El Marzouk S, Gahattamaneni R, Joshi SR, et al. (2008) The plasticity of estrogen receptor-DNA complexes: binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers. J Steroid Biochem Mol Biol 110: 186-195.
    [105] Joshi SR, Ghattamaneni RB, Scovell WM (2011) Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol 25: 980-994.
    [106] Lu W, Peterson R, Dasgupta A, et al. (2000) Influence of HMGB-1 and adenovirus oncoprotein E1A on early stages of transcriptional preinitiation complex assembly. J Biol Chem 275: 35006-35012.
    [107] Watson M, Stott K, Cato J, et al. (2014) Characterization of the interaction between HMGB1 and H3—a possible means of positioning HMGB1 in chromatin. Nucleic Acids Res 42: 848-859.
    [108] Kawase T, Sato K, Ueda T, et al. (2008) Distinct domains in HMGB1 are involved in specific intramolecular and nucleosomal interactions. Biochemistry 47: 13991-13996.
    [109] Ueda T, Chou H, Kawase T, et al. (2004) Acidic tail of HMGB1 is required for its target binding to nucleosome linker DNA and transcriptional stimulation. Biochemistry 45: 9901-9908.
    [110] Ferreira H, Somers J, Webster R, et al. (2007) Histone tails and the H3 alphaN helix regulate nucleosome mobility and stability. Mol Cell Biol 27: 4037-4048.
    [111] Belandia B, Orford RL, Hurst HC, et al. (2002) Targeting of SWI/SNF chromatin remodeling complexes to estrogen-responsive genes. EMBO J 21: 4094-4103.
    [112] Joshi SR, Sarpong YC, Peterson RC, et al. (2012) Nucleosome dynamics: HMGB1 relaxes canonical nucleosome structure to facilitate estrogen receptor binding. Nucleic Acids Res 40: 10161-10171.
    [113] Schnitzler G, Sif S, Kingston RE (1998) Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state. Cell 94: 17-27
    [114] Ulyanova NP, Schnitzler GR (2007) Inverted factor access and slow reversion characterize SWI/SNF-altered nucleosome dimer. J Biol Chem 282: 1018-1028.
    [115] Scovell WM (2016) High mobility group protein 1: A collaborator in nucleosome dynamics and estrogen-responsive gene expression. World J Biol Chem 7: 206-222.
    [116] Catez F, Yang H, Tracey KJ, et al. (2004) Network of dynamic interactions between histone H1 and high-mobility-group protein in chromatin. Mol Cell Biol 24: 4321-4328.
    [117] Cheung E, Zarifyan AS, Kraus WL (2002) Histone H1 represses estrogen receptor α transcriptional activity by selectively inhibiting receptor-mediated transcription initiation. Mol Cell Biol 22: 2463-2471.
    [118] Privalov PL, Dragan AI, Crane-Robinson C (2009) The cost of bending. Trends Biochem Sci 34: 464-470.
    [119] Yang Z, Zheng C, Thiriet C, et al. (2005) The core histone N-terminal tail domain negatively regulate binding of transcription factor IIIA to a nucleosome containing a 5S RNA gene via a novel mechanism. Mol Cell Biol 25: 241-249.
    [120] Vettese-Dadey M, Walter P, Chen H, et al. (1994) Role of the histone amino termini in facilitating binding of a transcription factor GAL4-AH to nucleosome cores. Mol Cell Biol 14: 970-981.
    [121] Vignali M, Steger DJ, Neely KE, et al. (2000) Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes. EMBO J 19: 2629-2640.
    [122] Polach KJ, Lowary PT, Widom J (2000) Effects of core histone tail domains on the equilibrium constants for dynamic site accessibility in nucleosomes. J Mol Biol 298: 211-223.
    [123] Brower-Toland B, Wacker DA, Fulbright RM, et al. (2005) Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes J Mol Biol 346: 135-146.
    [124] Heo K, Kim B, Kim K, et al. (2007) Isolation and characterization of proteins associated with histone H3 tails in vivo. J Biol Chem 282: 15476-15483.
    [125] Stros M (1987) Binding of non-histone chromosomal protein HMGB1 to histone H3 in nucleosome detected by photochemical crosslinking. Biochem Biophys Res Commun 147: 301-308.
    [126] Nardulli AM, Shapiro DJ (1992) Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA binding. Mol Cell Biol 12: 2037-2042.
    [127] Nardulli AM, Grobner C, Cotter D (1995) Estrogen receptor-induced bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence. Mol Endocrinol 9: 1064-1076.
    [128] Sahu G, Wang D, Chen CB, et al. (2010) p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element. J Biol Chem 285: 1321-1332.
    [129] Porier MG, Bussiek M, Langowski J, et al. (2008) Spontaneous access to DNA target sites in folded chromatin fibers. J Mol Biol 379: 772-786.
    [130] Tims HS, Gurunathan K, Levitus M, et al. (2011) Dynamics of nucleosome invasion by DNA binding proteins. J Mol Biol 411: 430-448.
    [131] Koshland DE Jr (1958) Application of a theory of enzyme specificity to protein synthesis. Proc Natl Acad Sci USA 44: 98-104.
    [132] Boehr DD, Nussinov R, Wright PE (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nature Chem Biol 5: 789-796.
    [133] Csermely P, Palotal R, Nussinov R (2010) Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci 35: 539-546.
    [134] Perutz MF (1978) Hemoglobin structure and respiratory transport. Sci Am 239: 92-125.
  • This article has been cited by:

    1. Suvendu Ghosh, Partha Sarathi Singha, Lakshmi Kanta Das, Debosree Ghosh, Systematic Review on Major Antiviral Phytocompounds from Common Medicinal Plants against SARS-CoV-2, 2024, 20, 15734064, 613, 10.2174/0115734064262843231120051452
    2. Kiran Shahzadi, Syed Majid Bukhari, Asma Zaidi, Tanveer A. Wani, Muhammad Saeed Jan, Seema Zargar, Umer Rashid, Umar Farooq, Aneela Khushal, Sara Khan, Novel Coumarin Derivatives as Potential Urease Inhibitors for Kidney Stone Prevention and Antiulcer Therapy: From Synthesis to In Vivo Evaluation, 2023, 16, 1424-8247, 1552, 10.3390/ph16111552
    3. Fatıma Elmusa, Muna Elmusa, Mini-Review on Coumarins: Sources, Biosynthesis, Bioactivity, Extraction and Toxicology, 2024, 11, 2149-0120, 933, 10.18596/jotcsa.1419322
    4. Binoy Varghese Cheriyan, Jaikumar Shanmugasundaram, Prakash Ramakrishnan, Kavitha Ramasamy, R. Karthikeyan, Sowmyalakshmi Venkataraman, Anitha Roy, Parameswari Royapuram Parthasarathy, Exploring the potential therapeutic benefits of 7-methoxy coumarin for neuropathy pain: an in vivo, in vitro, and in silico approach, 2024, 51, 0301-4851, 10.1007/s11033-024-09991-8
    5. Farnoosh Saadati, Amir Modarresi Chahardehi, Negar Jamshidi, Nazanin Jamshidi, Darioush Ghasemi, Coumarin: A natural solution for alleviating inflammatory disorders, 2024, 7, 25902571, 100202, 10.1016/j.crphar.2024.100202
    6. Ekin Kurtul, Esra Küpeli Akkol, Büşra Karpuz Ağören, Büşra Yaylacı, Özlem Bahadır Acıkara, Eduardo Sobarzo-Sánchez, Phytochemical investigation and assessment of the anti-inflammatory activity of four Heracleum taxa growing in Turkey, 2025, 15, 1663-9812, 10.3389/fphar.2024.1494786
    7. Diana Molina, Evelyn Angamarca, George Cătălin Marinescu, Roua Gabriela Popescu, Gabriela N. Tenea, Integrating Metabolomics and Genomics to Uncover Antimicrobial Compounds in Lactiplantibacillus plantarum UTNGt2, a Cacao-Originating Probiotic from Ecuador, 2025, 14, 2079-6382, 123, 10.3390/antibiotics14020123
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(5403) PDF downloads(1219) Cited by(1)

Figures and Tables

Figures(4)  /  Tables(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog